Table 1.
Clinicopathologic factor |
HDAC1 expression |
P value |
HDAC2 expression |
P value |
|||||
---|---|---|---|---|---|---|---|---|---|
– | + | – | + | ||||||
Gender | |||||||||
Male |
38 |
34 |
0.254† |
39 |
33 |
|
|||
Female |
9 |
14 |
0.532† |
10 |
13 |
0.372† |
|||
Age (years) | |||||||||
< 58 |
26 |
21 |
|
28 |
19 |
|
|||
≥ 58 |
21 |
27 |
0.532† |
21 |
27 |
0.123† |
|||
Histologic type | |||||||||
SCC |
22 |
23 |
|
25 |
20 |
|
|||
AC |
22 |
18 |
|
21 |
19 |
|
|||
Others |
3 |
7 |
0.366† |
3 |
7 |
0.339† |
|||
Differentiation | |||||||||
Well/Moderate |
33 |
20 |
|
33 |
20 |
|
|||
Poor |
14 |
28 |
0.005† |
16 |
26 |
0.019† |
|||
pTNM stage* | |||||||||
I/II |
34 |
24 |
|
35 |
23 |
|
|||
III/IV |
13 |
24 |
0.026† |
14 |
23 |
0.032† |
|||
Lymphatic metastasis | |||||||||
No |
27 |
21 |
|
28 |
20 |
|
|||
Yes | 20 | 27 | 0.182† | 21 | 26 | 0.183† |
SCC, squamous cell carcinoma; AC, adenocarcinoma.
*TNM staging system of the International Union Against Cancer (2010).
†Pearson’s χ2 test.